UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 110,365 Shares of Cognex Corporation $CGNX

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 10.2% in the second quarter, Holdings Channel.com reports. The institutional investor owned 976,599 shares of the scientific and technical instruments company’s stock after selling 110,365 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Cognex were worth $70,725,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Cognex in the 2nd quarter worth $1,158,123,000. Northwestern Mutual Wealth Management Co. increased its position in Cognex by 173,138.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after acquiring an additional 10,471,400 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Cognex by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company’s stock valued at $191,231,000 after acquiring an additional 1,258,629 shares during the period. Disciplined Growth Investors Inc. MN lifted its holdings in Cognex by 0.9% in the second quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company’s stock valued at $151,264,000 after acquiring an additional 40,927 shares during the period. Finally, Geode Capital Management LLC boosted its position in Cognex by 27.1% in the fourth quarter. Geode Capital Management LLC now owns 3,950,299 shares of the scientific and technical instruments company’s stock worth $142,154,000 after purchasing an additional 842,783 shares during the last quarter. 88.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CGNX has been the subject of a number of recent research reports. JPMorgan Chase & Co. upgraded Cognex from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $65.00 to $75.00 in a research note on Tuesday, May 26th. Stephens raised their price objective on shares of Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. The Goldman Sachs Group restated a “buy” rating and set a $91.00 target price on shares of Cognex in a research report on Friday, August 7th. Seaport Research Partners set a $75.00 target price on shares of Cognex in a report on Tuesday, May 26th. Finally, DA Davidson set a $65.00 price target on shares of Cognex and gave the stock a “neutral” rating in a research report on Monday, August 10th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Cognex currently has an average rating of “Moderate Buy” and a consensus target price of $75.64.

Cognex Trading Down 0.2%

Shares of CGNX opened at $59.94 on Thursday. The business’s 50 day moving average is $64.14 and its 200 day moving average is $59.82. Cognex Corporation has a 12-month low of $34.60 and a 12-month high of $72.88. The company has a market capitalization of $10.08 billion, a PE ratio of 58.19 and a beta of 1.49.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.03. Cognex had a return on equity of 13.50% and a net margin of 16.05%.The business had revenue of $291.26 million during the quarter, compared to the consensus estimate of $292.10 million. During the same period in the prior year, the company posted $0.25 EPS. The firm’s revenue for the quarter was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Equities research analysts predict that Cognex Corporation will post 1.68 earnings per share for the current year.

Cognex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be given a dividend of $0.085 per share. The ex-dividend date is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.6%. Cognex’s dividend payout ratio is currently 33.01%.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.